Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting

References

• Coyle JT, Price DL, DeLong MR. Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184–90
   PubMed Web of Science ®Google Scholar
• Giacobini E, Becker R. Development of drugs for Alzheimer therapy: a decade of progress. In: Giacobini E, Becker R., eds. Alzheimer disease: therapeutic strategies. Boston (MA): Birkhäuser; 1994:1–7
   Google Scholar
• Christodoulou C, Melville P, Scherl WF, et al. Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 2006;245:127–36
   PubMed Web of Science ®Google Scholar
• Haque S, Md S, Alam MI, et al. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm 2012;38:387–411
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Molinaro R, et al. Supramolecular devices to improve the treatment of brain diseases. Drug Discov Today 2011;16:311–24
   PubMed Web of Science ®Google Scholar
• Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm 2010;76:189–99
   PubMed Web of Science ®Google Scholar
• Pillay S, Pillay V, Choonara YE, et al. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm 2009;382:277–99
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310–16
   PubMed Web of Science ®Google Scholar
• Sehra S, Dhake AS. Formulation and evaluation of sustained release 611 microspheres of poly-lactide-co-glycolide containing tamoxifen citrate. J Microencaps 2005;22:521–8
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M. Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Develop Ind Pharm 1999;25:471–6
   PubMed Web of Science ®Google Scholar
• Avgoustakis K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Del 2004;1:321–33
   PubMedGoogle Scholar
• Fonseca C, Simões S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Rel 2002;83:273–86
   PubMed Web of Science ®Google Scholar
• Bala I, Hariharan S, Ravi Kumar MNV. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carriers 2004;21:387–422
   PubMed Web of Science ®Google Scholar
• Kumar MNVR, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as donepezil carriers. Biomaterials 2004;25:1771–7
   PubMed Web of Science ®Google Scholar
• Peltonen L, Koistinen P, Karjalainen M, et al. The effect of cosolvents on the formulation of nanoparticles from low molecular weight poly(l)lactide. AAPS PharmSciTech 2002;3:1–7
   Google Scholar
• Cui F, Oian F, Yin C. Preparation and characterization of mucoadhesive polymercoated nanoparticles. Int J Pharm 2006; 316:154–61
   PubMed Web of Science ®Google Scholar
• Dou H, Jiang M. Fabrication, characterization and drug loading of pH-dependent multi-morphological nanoparticles based on cellulose. Polym Int 2007;56:1206–12
   Web of Science ®Google Scholar
• Jeong YI, Cheon JB, Kim SH, et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 1998;51:169–78
   PubMed Web of Science ®Google Scholar
• Md S, Kumar M, Baboota S, et al. Preparation, characterization and evaluation of bromocriptine loaded chitosan nanoparticles for intranasal delivery. Sci Adv Mater 2012;2:1–12
   Google Scholar
• Reddy L, Sharma R, Chuttani K, et al. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution Studies. AAPS J 2004;6:23
   PubMed Web of Science ®Google Scholar
• Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine 2009;5:90–95
   PubMed Web of Science ®Google Scholar
• Allemann E, Gurny R, Deolker E. Drug loaded nanoparticles: preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993;39:173–91
   Web of Science ®Google Scholar
• Banerjee T, Mitra S, Singh AK, et al. Preparation and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002;243:93–105
   PubMed Web of Science ®Google Scholar
• Wisse E, Leeuw AM. Structural elements determining transport and exchange process in the liver. In: Daviss SS, Illum L, McVie JG, Tomlinson E., eds. Microspheres and drug therapy, pharmaceutical, immunological and medical aspects. Amsterdam: Elsevier; 1984:1–23
   Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319–27
   Web of Science ®Google Scholar
• Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19
   PubMed Web of Science ®Google Scholar
• Vila A, Sánchez A, Tobío M, et al. Design of biodegradable particles for protein delivery. J Control Release 2002;78:15–24
   PubMed Web of Science ®Google Scholar
• Reddy LH, Murthy RSR. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butylcyanoacrylate) nanoparticles synthesized by two different techniques. BioMed 2004;148:161–6
   Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65–81
   PubMed Web of Science ®Google Scholar
• Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. Curr Med Chem CNS Agents 2002;2:241–49
   Google Scholar
• Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 2004;4:484–8
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5–28
   PubMed Web of Science ®Google Scholar
• Fawaz F, Guyot M, Lagueny AM, Devissaguet JPH. Ciprofloxacin-loaded poly(isobutylcyanoacrylate) nanoparticles: preparation and characterization. Int J Pharm 1997;154:191–203
   Web of Science ®Google Scholar
• Wu Y, Yang W, Wang C, et al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005;295:235–45
   PubMed Web of Science ®Google Scholar
• Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 2011;7:4169–76
   PubMed Web of Science ®Google Scholar
• Nanda B, Murthy RSR. Preparation and characterization of chitosan lactate nanoparticles for the nasal delivery of enalaprilat. J Biomed Nanotechnol 2007;3:45–51
   Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm 2008;346:151–9
   PubMed Web of Science ®Google Scholar
• Tayade PT, Kale RD. Encapsulation of water-insoluble drug by a cross-linking technique: effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate. AAPS Pharm Sci 2004;6:1–8
   Web of Science ®Google Scholar
• Papadimitriou S, Papageorgiou GZ, Kanaze FI, et al. Nanoencapsulation of nimodipine in novel biocompatible poly (propylene-co-butylene succinate) aliphatic copolyesters for sustained release. J Nanomater 2009;2009:1–11
   Web of Science ®Google Scholar
• Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 2009;379:146–57
   PubMed Web of Science ®Google Scholar